Dimensional Fund Advisors LP Bio Path Holdings Inc Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$1.32 - $2.81 $3,614 - $7,693	-2,738 Reduced 16.69%	13,665 $20,000
Q3 2022 Nov 10, 2022	BUY	$3.18 - $4.43 $10,948 - $15,252	3,443 Added 26.57%	16,403 $52,000
Q2 2022 Aug 12, 2022	BUY	$2.83 - $4.02 $36,676 - $52,099	12,960 New	12,960 $50,000
Q1 2022 May 13, 2022	SELL	$2.99 - $4.17 $45,971 - $64,113	-15,375 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$5.13 - $6.78 $65,525 - $86,600	-12,773 Reduced 45.38%	15,375 $79,000

Q2 2021 Aug 12, 2021	BUY	$5.13 - $7.63 $53,469 - $79,527	10,423 Added 58.8%	28,148 $188,000
Q1 2021 May 14, 2021	BUY	$3.63 - $11.77 $64,341 - $208,623	17,725 New	17,725 $124,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $13M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.